Normal weight obesity (NWO) is defined as having a normal body mass index (BMI), but a high body fat mass. There is growing interest in individuals with NWO, which is an underdiagnosed and understudied group, because of their increased risk for cardiometabolic morbidity and mortality. In this review, we summarized the definition, prevalence, etiology, pathophysiology, and cardiovascular outcomes seen in NWO. We have also summarized the available literature on interventions for NWO. There is a wide variation in the body fat percent cutoffs used to diagnose excess body fat. Hence, the prevalence rates of NWO vary between different populations and studies. It is estimated that about 30 million Americans have NWO and the worldwide prevalence ranges from 4.5% to 22%. Genetics, diet, and physical activity are related to NWO. However, etiological factors are not clear. Changes in body composition, inflammation, oxidative stress are present in NWO in comparison to normal weight lean (NWL) who have a normal BMI and normal body fat amount. Furthermore, cardiometabolic changes are observed and some are subclinical. Thus, screening for NWO will enhance the primary prevention of cardiovascular disease. Due to the use of various body fat percent cutoffs and methods to measure body fat, it is challenging to compare between studies. Researchers working in this field should ideally work towards developing standard body fat percent cutoffs for diagnosing NWO. There are many gaps in the literature on NWO unlike for overt obesity and future studies should explore the etiology, molecular mechanisms, and adipose tissue changes of NWO as well as conduct well planned and executed randomized controlled trials testing dietary, physical, and behavioral interventions for NWO in both males and females of different racial and age groups.
Your institute does not have access to this article
Subscribe to Journal
Get full journal access for 1 year
only $9.92 per issue
All prices are NET prices.
VAT will be added later in the checkout.
Tax calculation will be finalised during checkout.
Get time limited or full article access on ReadCube.
All prices are NET prices.
Obesity: World Health Organization. https://www.who.int/topics/obesity/en/. Accessed 15 Jun 2020.
Okorodudu DO, Jumean MF, Montori VM, Romero-Corral A, Somers VK, Erwin PJ, et al. Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis. Int J Obes. 2010;34:791.
De Lorenzo A, Soldati L, Sarlo F, Calvani M, Di Lorenzo N, Di Renzo L. New obesity classification criteria as a tool for bariatric surgery indication. World J Gastroenterol. 2016;22:681–703.
Franco LP, Morais CC, Cominetti C. Normal-weight obesity syndrome: diagnosis, prevalence, and clinical implications. Nutr Rev. 2016;74:558–70.
Romero-Corral A, Somers VK, Sierra-Johnson J, Korenfeld Y, Boarin S, Korinek J, et al. Normal weight obesity: a risk factor for cardiometabolic dysregulation and cardiovascular mortality. Eur Heart J. 2010;31:737–46.
Badoud F, Perreault M, Zulyniak MA, Mutch DM. Molecular insights into the role of white adipose tissue in metabolically unhealthy normal weight and metabolically healthy obese individuals. FASEB J. 2015;29:748–58.
Gujral UP, Vittinghoff E, Mongraw-Chaffin M, Vaidya D, Kandula NR, Allison M, et al. Cardiometabolic abnormalities among normal-weight persons from five racial/ethnic groups in the United States: a cross-sectional analysis of two cohort studies. Ann Intern Med. 2017;166:628–36.
Bosomworth NJ. Normal-weight central obesity: unique hazard of the toxic waist. Can Fam Phys. 2019;65:399–408.
Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Aging. 2019;48:16–31.
Marques-Vidal P, Chiolero A, Paccaud F. Large differences in the prevalence of normal weight obesity using various cut-offs for excess body fat. Eur e-J Clin Nutr Metab. 2008;3:e159–e62.
Batsis JA, Sahakyan KR, Rodriguez-Escudero JP, Bartels SJ, Somers VK, Lopez-Jimenez F. Normal weight obesity and mortality in United States subjects >/=60 years of age (from the Third National Health and Nutrition Examination Survey). Am J Cardiol. 2013;112:1592–8.
Tayefi M, Tayefi B, Darroudi S, Mohammadi-Bajgiran M, Mouhebati M, Heidari-Bakavoli A, et al. There is an association between body fat percentage and metabolic abnormality in normal weight subjects: Iranian large population. Transl Metab Syndr Res. 2019;2:11–6.
Čuta M, Bařicová K, Černý D, Sochor O. Normal-weight obesity frequency in the Central European urban adult female population of Brno, Czech Republic. Cent Eur J Public Health. 2019;27:131–4.
Dickey RA, Bartuska D, Bray GW, Callaway CW, Davidson ET, Feld S, et al. AACE/ACE Position statement on the prevention, diagnosis, and treatment of obesity (1998 revision). Endocr Pract. 1998;4:297–350.
American College of Sports Medicine. Health-related physical fitness testing and interpretation. In: Riebe D, Liguori G, Ehrman JK, Magal M, editors. ACSM’s Guidelines for exercise testing and prescription 10th edition: Wolters Kluwer; 2017. p. 77–80.
Ho-Pham LT, Campbell LV, Nguyen TV. More on body fat cutoff points. Mayo Clinic Proc. 2011;86:584.
Berg C, Strandhagen E, Mehlig K, Subramoney S, Lissner L, Björck L. Normal weight adiposity in a Swedish population: how well is cardiovascular risk associated with excess body fat captured by BMI? Obes Sci Pract. 2015;1:50–8.
Mannisto S, Harald K, Kontto J, Lahti-Koski M, Kaartinen NE, Saarni SE, et al. Dietary and lifestyle characteristics associated with normal-weight obesity: the National FINRISK 2007 Study. Br J Nutr. 2014;111:887–94.
Ohlsson B, Manjer J. Sociodemographic and lifestyle factors in relation to overweight defined by BMI and “normal-weight obesity”. J Obes. 2020;2020. https://doi.org/10.1155/2020/2070297.
Marques-Vidal P, Pecoud A, Hayoz D, Paccaud F, Mooser V, Waeber G, et al. Normal weight obesity: relationship with lipids, glycaemic status, liver enzymes and inflammation. Nutr Metab Cardiovasc Dis. 2010;20:669–75.
Batsis JA, Sahakyan KR, Rodriguez-Escudero JP, Bartels SJ, Lopez-Jimenez F. Normal weight obesity and functional outcomes in older adults. Eur J Intern Med. 2014;25:517–22.
García-Hermoso A, Agostinis-Sobrinho C, Camargo-Villalba GE, González-Jiménez NM, Izquierdo M, Correa-Bautista JE, et al. Normal-weight obesity is associated with poorer cardiometabolic profile and lower physical fitness levels in children and adolescents. Nutrients. 2020;12:4.
Madeira FB, Silva AA, Veloso HF, Goldani MZ, Kac G, Cardoso VC, et al. Normal weight obesity is associated with metabolic syndrome and insulin resistance in young adults from a middle-income country. PLoS ONE. 2013;8:e60673.
Moy FM, Loh DA. Cardiometabolic risks profile of normal weight obese and multi-ethnic women in a developing country. Maturitas. 2015;81:389–93.
Martinez KE, Tucker LA, Bailey BW, LeCheminant JD. Expanded normal weight obesity and insulin resistance in us adults of the national health and nutrition examination survey. J Diab Res. 2017;2017:9502643.
He H, Pan L, Liu F, Ma J, Hu Z, Wang L, et al. Expanded normal weight obesity and blood pressure in Chinese adults: a community-based crosss-ectional study. Austral J Prim Health. 2019;25:256–263.
Kim MK, Han K, Kwon HS, Song KH, Yim HW, Lee WC, et al. Normal weight obesity in Korean adults. Clinical Endocrinology. 2014;80:214–20.
Kosmala W, Jedrzejuk D, Derzhko R, Przewlocka-Kosmala M, Mysiak A, Bednarek-Tupikowska G. Left ventricular function impairment in patients with normal-weight obesity: contribution of abdominal fat deposition, profibrotic state, reduced insulin sensitivity, and proinflammatory activation. Circ Cardiovasc Imaging. 2012;5:349–356.
Kang S, Kyung C, Park JS, Kim S, Lee S-P, Kim MK, et al. Subclinical vascular inflammation in subjects with normal weight obesity and its association with body fat: an 18F-FDG-PET/CT study. Cardiovasc Diabetol. 2014;13:70.
Di Renzo L, Galvano F, Orlandi C, Bianchi A, Di Giacomo C, La, et al. Oxidative stress in normal-weight obese syndrome. Obesity. 2010;18:2125–30.
De Lorenzo A, Martinoli R, Vaia F, Di, Renzo L. Normal weight obese (NWO) women: an evaluation of a candidate new syndrome. Nutr Metab Cardiovasc Dis. 2006;16:513–23.
De Lorenzo A, Del Gobbo V, Premrov MG, Bigioni M, Galvano F, Di Renzo L. Normal-weight obese syndrome: early inflammation? Am J Clin Nutr. 2007;85:40–5.
Di Renzo L, Bigioni M, Bottini FG, Del Gobbo V, Premrov MG, Cianci R, et al. Normal weight obese syndrome: role of single nucleotide polymorphism of IL-1 5Ralpha and MTHFR 677C–>T genes in the relationship between body composition and resting metabolic rate. Eur Rev Med Pharmacol Sci. 2006;10:235–45.
Di Renzo L, Sarlo F, Petramala L, Iacopino L, Monteleone G, Colica C, et al. Association between -308 G/A TNF-alpha polymorphism and appendicular skeletal muscle mass index as a marker of sarcopenia in normal weight obese syndrome. Dis Mark. 2013;35:615–23.
Karkhaneh M, Qorbani M, Mohajeri-Tehrani MR, Hoseini S. Association of serum complement C3 with metabolic syndrome components in normal weight obese women. J Diab Metab Disord. 2017;16:49.
De Lorenzo A, Costacurta M, Merra G, Gualtieri P, Cioccoloni G, Marchetti M, et al. Can psychobiotics intake modulate psychological profile and body composition of women affected by normal weight obese syndrome and obesity? A double blind randomized clinical trial. J Transl Med. 2017;15:135.
Ferreira FC, Bertucci DR, Barbosa MR, Nunes JE, Botero JP, Rodrigues MF, et al. Circuit resistance training in women with normal weight obesity syndrome: body composition, cardiometabolic and echocardiographic parameters, and cardiovascular and skeletal muscle fitness. J Sports Med Phys Fitness. 2017;57:1033–44.
Di Renzo L, Rizzo M, Sarlo F, Colica C, Iacopino L, Domino E, et al. Effects of dark chocolate in a population of normal weight obese women: a pilot study. Eur Rev Med Pharmacol Sci. 2013;17:2257–66.
Bellissimo MP, Cai Q, Ziegler TR, Liu KH, Tran PH, Vos MB, et al. Plasma high-resolution metabolomics differentiates adults with normal weight. Obesity from lean individuals. Obesity. 2019;27:1729–37.
Wiklund P, Törmäkangas T, Shi Y, Wu N, Vainionpää A, Alen M. et al. Normal‐weight obesity and cardiometabolic risk: a 7‐year longitudinal study in girls from prepuberty to early adulthood. Obesity. 2017;25:1077–82.
Musalek M, Parizkova J, Godina E, Bondareva E, Kokstejn J, Jirovec J, et al. Poor skeletal robustness on lower extremities and weak lean mass development on upper arm and calf: normal weight obesity in middle-school-aged children (9 to 12). Front Pediatr. 2018;6:371.
Cheng S, Wiklund P. The effects of muscle mass and muscle quality on cardio-metabolic risk in peripubertal girls: a longitudinal study from childhood to early adulthood. Int J Obes. 2018;42:648–54.
Musalek M, Kokstejn J, Papez P, Scheffler C, Mumm R, Czernitzki AF, et al. Impact of normal weight obesity on fundamental motor skills in pre-school children aged 3 to 6 years. Anthropol Anz. 2017;74:203–12.
Batsis JA, Mackenzie TA, Lopez-Jimenez F, Bartels SJ. Normal-weight obesity and disability in older adults: data from the national health and nutrition examination study 1999–2004. J Am Geriatr Soc. 2016;64:1367–8.
Correa-Rodríguez M, González-Ruíz K, Rincón-Pabón D, Izquierdo M, García-Hermoso A, Agostinis-Sobrinho C, et al. Normal-weight obesity is associated with increased cardiometabolic risk in young adults. Nutrients. 2020;12:1106.
Jia A, Xu S, Xing Y, Zhang W, Yu X, Zhao Y, et al. Prevalence and cardiometabolic risks of normal weight obesity in Chinese population: a nationwide study. Nutr Metab Cardiovasc Dis. 2018;28:1045–53.
Olafsdottir AS, Torfadottir JE, Arngrimsson SA. Health behavior and metabolic risk factors associated with normal weight obesity in adolescents. PLoS ONE. 2016;11:e0161451.
Salsberry PJ, Reagan PB. Dynamics of early childhood overweight. Pediatrics. 2005;116:1329–38.
Wahi G, Anand SS. Race/ethnicity, obesity, and related cardio-metabolic risk factors: a life-course perspective. Curr Cardiovasc Risk Rep. 2013;7:326–35.
Ramsaran C, Maharaj RG. Normal weight obesity among young adults in Trinidad and Tobago: prevalence and associated factors. Int J Adolesc Med Health. 2017;29.
Amani R, Parohan M, Jomehzadeh N, Haghighizadeh MH. Dietary and biochemical characteristics associated with normal-weight obesity. Int J Vitamin Nutr Res. 2019;89:331–6.
Yaguchi-Tanaka Y, Kawagoshi Y, Sasaki S, Fukao A. Cross-sectional study of possible association between rapid eating and high body fat rates among female Japanese college students. J Nutr Sci Vitaminol. 2013;59:243–9.
Dhurandhar NV, Schoeller D, Brown AW, Heymsfield SB, Thomas D, Sørensen TIA, et al. Energy balance measurement: when something is not better than nothing. Int J Obes. 2015;39:1109–13.
Zhang M, Schumann M, Huang T, Tormakangas T, Cheng S. Normal weight obesity and physical fitness in Chinese university students: an overlooked association. BMC Public Health. 2018;18:1334.
Ortega Francisco B, Lavie Carl J, Blair Steven N. Obesity and cardiovascular disease. Circ Res. 2016;118:1752–70.
Di Renzo L, Bigioni M, Del Gobbo V, Premrov MG, Barbini U, Di Lorenzo N, et al. Interleukin-1 (IL-1) receptor antagonist gene polymorphism in normal weight obese syndrome: relationship to body composition and IL-1 alpha and beta plasma levels. Pharmacol Res. 2007;55:131–8.
Di Renzo L, Gloria-Bottini F, Saccucci P, Bigioni M, Abenavoli L, Gasbarrini G, et al. Role of interleukin-15 receptor alpha polymorphisms in normal weight obese syndrome. Int J Immunopathol Pharmacol. 2009;22:105–13.
Di Renzo L, Bertoli A, Bigioni M, Del Gobbo V, Premrov MG, Calabrese V, et al. Body composition and -174G/C interleukin-6 promoter gene polymorphism: association with progression of insulin resistance in normal weight obese syndrome. Curr Pharm Des. 2008;14:2699–706.
Franco LP, Goncalves Zardini Silveira A, Sobral de Assis Vasconcelos Lima R, Horst MA, Cominetti C. APOE genotype associates with food consumption and body composition to predict dyslipidaemia in Brazilian adults with normal-weight obesity syndrome. Clin Nutr. 2018;37:1722–7.
Ballak DB, Stienstra R, Tack CJ, Dinarello CA, van Diepen JA. IL-1 family members in the pathogenesis and treatment of metabolic disease: focus on adipose tissue inflammation and insulin resistance. Cytokine. 2015;75:280–90.
Lee B-C, Lee J. Cellular and molecular players in adipose tissue inflammation in the development of obesity-induced insulin resistance. Biochim Biophys Acta. 2014;1842:446–62.
Di Renzo L, Gratteri S, Sarlo F, Cabibbo A, Colica C, De, et al. Individually tailored screening of susceptibility to sarcopenia using p53 codon 72 polymorphism, phenotypes, and conventional risk factors. Dis Mark. 2014;2014:743634.
Ganguly P, Alam SF. Role of homocysteine in the development of cardiovascular disease. Nutr J. 2015;14:6.
Kim S, Kyung C, Park JS, Lee SP, Kim HK, Ahn CW, et al. Normal-weight obesity is associated with increased risk of subclinical atherosclerosis. Cardiovasc Diabetol. 2015;14:58.
Jean N, Somers VK, Sochor O, Medina-Inojosa J, Llano EM, Lopez-Jimenez F. Normal-weight obesity: implications for cardiovascular health. Curr Atheroscler Rep. 2014;16:464.
Chen G-C, Arthur R, Iyengar NM, Kamensky V, Xue X, Wassertheil-Smoller S, et al. Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index. Eur Heart J. 2019;40:2849–55.
Unamuno X, Gómez-Ambrosi J, Rodríguez A, Becerril S, Frühbeck G, Catalán V. Adipokine dysregulation and adipose tissue inflammation in human obesity. Eur J Clin Investig. 2018;48:e12997.
Thomas EL, Frost G, Taylor-Robinson SD, Bell JD. Excess body fat in obese and normal-weight subjects. Nutr Res Rev. 2012;25:150–61.
Liu Z, Tang Q, Wen J, Tang Y, Huang D, Huang Y, et al. Elevated serum complement factors 3 and 4 are strong inflammatory markers of the metabolic syndrome development: a longitudinal cohort study. Sci Rep. 2016;6:18713.
Karkhaneh M, Qorbani M, Ataie-Jafari A, Mohajeri-Tehrani MR, Asayesh H, Hosseini S. Association of thyroid hormones with resting energy expenditure and complement C3 in normal weight high body fat women. Thyroid Res. 2019;12:9.
Badimon L, Peña E, Arderiu G, Padró T, Slevin M, Vilahur G, et al. C-reactive protein in atherothrombosis and angiogenesis. Front Immunol. 2018;9:430-.
Shea JL, King MT, Yi Y, Gulliver W, Sun G. Body fat percentage is associated with cardiometabolic dysregulation in BMI-defined normal weight subjects. Nutr Metab Cardiovasc Dis. 2012;22:741–7.
Conde J, Scotece M, Gómez R, López V, Gómez-Reino JJ, Lago F, et al. Adipokines: biofactors from white adipose tissue. A complex hub among inflammation, metabolism, and immunity. BioFactors. 2011;37:413–20.
Kishimoto N, Okita K, Takada S, Sakuma I, Saijo Y, Chiba H, et al. Lipoprotein metabolism, insulin resistance, and adipocytokine levels in Japanese female adolescents with a normal body mass index and high body fat mass. Circ J. 2009;73:534–9.
Miazgowski T, Safranow K, Krzyzanowska-Swiniarska B, Iskierska K, Widecka K. Adiponectin, visfatin and regional fat depots in normal weight obese premenopausal women. Eur J Clin Investig. 2013;43:783–90.
Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di Rosa G, et al. Oxidative stress in obesity: a critical component in human diseases. Int J Mol Sci. 2014;16:378–400.
Vona R, Gambardella L, Cittadini C, Straface E, Pietraforte D. Biomarkers of oxidative stress in metabolic syndrome and associated diseases. Oxid Med Cell Longev. 2019;2019:8267234.
Mehrabian S, Taheri E, Karkhaneh M, Qorbani M, Hosseini S. Association of circulating irisin levels with normal weight obesity, glycemic and lipid profile. J Diabet Metab Disord. 2015;15:17.
Perakakis N, Triantafyllou GA, Fernández-Real JM, Huh JY, Park KH, Seufert J, et al. Physiology and role of irisin in glucose homeostasis. Nat Rev Endocrinol. 2017;13:324–37.
Jia J, Yu F, Wei W-P, Yang P, Zhang R, Sheng Y, et al. Relationship between circulating irisin levels and overweight/obesity: a meta-analysis. World J Clin Cases. 2019;7:1444–55.
Di Renzo L, Del Gobbo V, Bigioni M, Premrov MG, Cianci R, De Lorenzo A. Body composition analyses in normal weight obese women. Eur Rev Med Pharmacol Sci. 2006;10:191–6.
Wannamethee SG, Atkins JL. Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity. Proc Nutr Soc. 2015;74:405–12.
Yasuda T. Anthropometric, body composition, and somatotype characteristics of Japanese young women: Implications for normal-weight obesity syndrome and sarcopenia diagnosis criteria. Interv Med Appl Sci. 2019;11:117–21.
Hart NH, Nimphius S, Rantalainen T, Ireland A, Siafarikas A, Newton RU. Mechanical basis of bone strength: influence of bone material, bone structure and muscle action. J Musculosk Neuronal Interact. 2017;17:114–39.
Kelly OJ, Gilman JC, Boschiero D, Ilich JZ. Osteosarcopenic obesity: current knowledge, revised identification criteria and treatment principles. Nutrients. 2019;11:747.
Paredes S, Fonseca L, Ribeiro L, Ramos H, Oliveira JC, Palma I. Novel and traditional lipid profiles in metabolic syndrome reveal a high atherogenicity. Sci Rep. 2019;9:11792.
Malandrino N, Capristo E, Taveira TH, Mingrone G, Wu W-C. Cognitive function in individuals with normal weight obesity: results from the third national health and nutrition examination survey (NHANES III). J Alzheimer’s Dis. 2018;65:125–35.
Yates KF, Sweat V, Yau PL, Turchiano MM, Convit A. Impact of metabolic syndrome on cognition and brain. Arterioscl Thromb Vasc Biol. 2012;32:2060–7.
Pashkow FJ. Oxidative stress and inflammation in heart disease: do antioxidants have a role in treatment and/or prevention. Int J Inflamm. 2011;2011:514623.
Iyengar NM, Arthur R, Manson JE, Chlebowski RT, Kroenke CH, Peterson L, et al. Association of body fat and risk of breast cancer in postmenopausal women with normal body mass index: a secondary analysis of a randomized clinical trial and observational study. JAMA Oncol. 2019;5:155–63.
Micucci C, Valli D, Matacchione G, Catalano A. Current perspectives between metabolic syndrome and cancer. Oncotarget. 2016;7:38959–72.
Chooi YC, Ding C, Chan Z, Choo J, Sadananthan SA, Michael N, et al. Moderate weight loss improves body composition and metabolic function in metabolically unhealthy lean subjects. Obesity. 2018;26:1000–7.
Jung W-S, Hwang H, Kim J, Park H-Y, Lim K. Comparison of excess post-exercise oxygen consumption of different exercises in normal weight obesity women. J Exerc Nutr Biochem. 2019;23:22–7.
Lavie CJ, Laddu D, Arena R, Ortega FB, Alpert MA, Kushner RF. Healthy weight and obesity prevention: JACC health promotion series. J Am Coll Cardiol. 2018;72:1506–31.
Di Renzo L, Tyndall E, Gualtieri P, Carboni C, Valente R, Ciani AS, et al. Association of body composition and eating behavior in the normal weight obese syndrome. Eating Weight Disord. 2016;21:99–106.
Maffetone PB, Rivera-Dominguez I, Laursen PB. Overfat and underfat: new terms and definitions long overdue. Front Public Health. 2016;4:279.
Gómez-Ambrosi J, Silva C, Galofré JC, Escalada J, Santos S, Millán D, et al. Body mass index classification misses subjects with increased cardiometabolic risk factors related to elevated adiposity. Int J Obes. 2011;36:286.
Ceniccola GD, Castro MG, Piovacari SMF, Horie LM, Corrêa FG, Barrere APN, et al. Current technologies in body composition assessment: advantages and disadvantages. Nutrition. 2019;62:25–31.
This work was supported by startup funds from Texas Tech University.
Conflict of interest
Dr. Nadeeja Wijayatunga declares no competing financial interests. Co-author, Dr. Emily Dhurandhar reports salary from Obthera, Inc, outside the submitted work for providing nutrition counseling to clients and developing nutrition digital therapeutics.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wijayatunga, N.N., Dhurandhar, E.J. Normal weight obesity and unaddressed cardiometabolic health risk—a narrative review. Int J Obes 45, 2141–2155 (2021). https://doi.org/10.1038/s41366-021-00858-7
European Journal of Clinical Nutrition (2022)